Supply Chain

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Overcoming supply chain woes will require digital intervention.

What are the key decisions that need to be made for cell therapy supply chains?

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

How SaudiVax is partnering to help patients in the Middle East and Africa to access advanced medicine.

A short guide to strengthening raw materials supply chains in the biopharma industry, featuring Luis Bianchi Pintos from Thermo Fisher Scientific.

Building and managing an advanced therapy collection network is a significant challenge, but there is another route.

What did the industry learn about logistics during COVID vaccine rollout, and how will it make sure nobody gets left behind?

While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?